These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Grainger DJ Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):399-404. PubMed ID: 14699019 [TBL] [Abstract][Full Text] [Related]
9. Atherosclerosis: cell biology and lipoproteins. Lu H; Daugherty A Curr Opin Lipidol; 2009 Dec; 20(6):528-9. PubMed ID: 19935204 [No Abstract] [Full Text] [Related]
10. State of the art: atherosclerosis in a limited edition. Rader DJ; FitzGerald GA Nat Med; 1998 Aug; 4(8):899-900. PubMed ID: 9701240 [No Abstract] [Full Text] [Related]
11. Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice. Babaev VR; Ding L; Reese J; Morrow JD; Breyer MD; Dey SK; Fazio S; Linton MF Circulation; 2006 Jan; 113(1):108-17. PubMed ID: 16380543 [TBL] [Abstract][Full Text] [Related]
12. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice. Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605 [TBL] [Abstract][Full Text] [Related]
13. Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Gojova A; Brun V; Esposito B; Cottrez F; Gourdy P; Ardouin P; Tedgui A; Mallat Z; Groux H Blood; 2003 Dec; 102(12):4052-8. PubMed ID: 12920022 [TBL] [Abstract][Full Text] [Related]
14. Atherogenesis on the chopping block. Gargalovic PS Cell Metab; 2009 May; 9(5):399-401. PubMed ID: 19416707 [TBL] [Abstract][Full Text] [Related]
15. Effect of macrophage ApoE on atherosclerosis in LDL-receptor deficient mice. Tennert C; Teupser D; Mueller MA; Wilfert W; Renner-Müller I; Stein O; Stein Y; Sippel AE; Wolf E; Thiery J Biochem Biophys Res Commun; 2007 Sep; 361(3):574-9. PubMed ID: 17669363 [TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury. Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953 [TBL] [Abstract][Full Text] [Related]
17. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice. Oe S; Lemmer ER; Conner EA; Factor VM; Levéen P; Larsson J; Karlsson S; Thorgeirsson SS Hepatology; 2004 Nov; 40(5):1098-105. PubMed ID: 15389868 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta: taking control of T cells' life and death. Horwitz DA Immunity; 2006 Sep; 25(3):399-401. PubMed ID: 16979574 [TBL] [Abstract][Full Text] [Related]
20. Divergent effects of the catalytic and bridging functions of hepatic lipase on atherosclerosis. Dichek HL; Qian K; Agrawal N Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1696-702. PubMed ID: 15205216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]